JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bloch-Shilderman, E.
Right arrow Articles by Lazarovici, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bloch-Shilderman, E.
Right arrow Articles by Lazarovici, P.

Vol. 301, Issue 3, 953-962, June 2002

Pardaxin Stimulation of Phospholipases A2 and Their Involvement in Exocytosis in PC-12 Cells

Eugenia Bloch-Shilderman, Saleh Abu-Raya1 , Victoria Trembovler, Hassia Boschwitz, Arie Gruzman, Michal Linial and Philip Lazarovici

Department of Pharmacology and Experimental Therapeutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel (E.B.-S., S.A.-R., V.T., A.G., P.L.); and Department of Biological Chemistry, Life Sciences Institute, The Hebrew University of Jerusalem, Israel (H.B., M.L.)

Pardaxin (PX) is a voltage-dependent ionophore that stimulates catecholamine exocytosis from PC-12 pheochromocytoma cells both in the presence and absence of extracellular calcium. Using a battery of phospholipase A2 inhibitors we show that PX stimulation of phospholipase A2 (PLA2) enzymes is coupled with induction of exocytosis. We investigated the relationship between PX-induced PLA2 activity and neurotransmitter release by measuring the levels of arachidonic acid (AA), prostaglandin E2 (PGE2), and dopamine release. In the presence of extracellular calcium, the cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone (AACOCF3) inhibited by 100, 70, and 73%, respectively, the release of AA, PGE2, and dopamine induced by PX. The mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor 2'-amino-3'-methoxyflavone (PD98059) reduced by 100 and 82%, respectively, the release of AA and PGE2 induced by PX. In the absence of extracellular calcium, the calcium-independent PLA2 (iPLA2) inhibitors methyl arachidonyl fluorophosphonate, AACOCF3, and bromoenol lactone (BEL) inhibited by 80 to 90% PX stimulation of AA release, by 65 to 85% PX stimulation of PGE2 release, and by 80 to 90% PX-induced dopamine release. Using vesicle fusion-based enzyme-linked immunosorbent assay we found similar levels of inhibition of PX-induced exocytosis by these inhibitors. Also, PX induced the formation of soluble N-ethylmaleimide-sensitive factor attachment protein receptor complexes, an effect that was augmented by N-methylmaleimide. This complex formation was completely inhibited by BEL. Botulinum toxins type C1 and F significantly inhibited the release of AA, PGE2, and dopamine induced by PX. Our data suggest that PX stimulates exocytosis by activating cystolic PLA2 and iPLA2, leading to the generation of AA and eicosanoids, which, in turn, stimulate vesicle competence for fusion and neurotransmitter release.


1 Current address: Hadassah Academic College, Haneviim Street 37, P.O. Box 1114, Jerusalem 91010, Israel.


0022-3565/02/3013-0953$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J BiochemHome page
A. A. Sattar and R. Haque
Cytosolic PLA2 in Zymogen Granule Fusion and Amylase Release: Inhibition of GTP-induced Fusion by Arachidonyl Trifluoromethyl Ketone Points to cPLA2 in G-Protein-mediated Secretory Vesicle Fusion
J. Biochem., January 1, 2007; 141(1): 77 - 84.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.